Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is N/A as of Tuesday, October 6, 2026.
ENTERPRISE VALUE (EV)
N/A
Apnimed, Inc.
Market Cap
$851.42M
Enterprise Value (EV)
N/A
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Apnimed, Inc. (APMD) | $851.42M | N/A |
| Jade Biosciences, Inc. (JBIO)vs › | $852.65M | $746.02M |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $848.19M | $796.07M |
| Beta Bionics, Inc. (BBNX)vs › | $857.50M | $819.70M |
| Alumis Inc. (ALMS)vs › | $830.08M | $802.80M |
| Ardelyx, Inc. (ARDX)vs › | $823.84M | $982.84M |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $884.63M | $866.45M |
| InMode Ltd. (INMD)vs › | $813.07M | $421.34M |
| Arbutus Biopharma Corp (ABUS)vs › | $896.17M | $880.62M |
| Gyre Therapeutics, Inc. (GYRE)vs › | $804.39M | $764.52M |
Market Cap
$851.42M
Total Debt
N/A
Cash
N/A
Enterprise Value
N/A
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
